Molecular and Clinical Characteristics of Myotonic Dystrophy Type 1in Koreans

被引:13
|
作者
Kim, So Yeon
Kim, Ji Yeon [1 ]
Kim, Gyoung Pyoung
Sung, Jung-Jun [2 ]
Lim, Kyu Sang
Lee, Kwang-Woo [2 ]
Chae, Jong Hee [3 ]
Hong, Yoon-Ho [4 ]
Seong, Moon-Woo [5 ]
Park, Sung Sup
机构
[1] Seoul Natl Univ, Clin Res Inst, Dept Lab Med, Seoul Natl Univ Hosp,Coll Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Boramae Hosp, Dept Neurol, Seoul 110744, South Korea
[5] Natl Canc Ctr, Dept Lab Med, Goyang, South Korea
来源
KOREAN JOURNAL OF LABORATORY MEDICINE | 2008年 / 28卷 / 06期
关键词
Myotonic dystrophy type 1; DMPK gene; CTG; Trinucleotide repeat expansion; Polymerase chain reaction; Southern blot; Anticipation; Instability; Age of onset; Korean;
D O I
10.3343/kjlm.2008.28.6.483
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background : Myotonic dystrophy type 1 (DM1) is an autosomal-dominant muscular dystrophy caused by expansion of cytosine-thymine-guanine (CTG) trinucleotide repeats in the myotonic dystrophy protein kinase (DMPK) gene. The clinical features of DM1 are multisystemic and highly variable, and the unstable nature of CTG expansion causes wide genotypic and phenotypic presentations. The aim of this study was to characterize the molecular and clinical spectra of DM1 in Koreans. Methods : The CTG repeats of 283 Korean individuals were tested by PCR fragment analysis and Southern blot. The following characteristics were assessed retrospectively: spectrum of CTG expansions, clinical findings, genotype-phenotype correlation, anticipation. and genetic instability. Results : One-hundred twenty-four patients were confirmed as DM1 by molecular tests, and the CTG expansions ranged from 50 to 2,770 repeats (median 480 repeats). The most frequent clinical features were myotonia, muscular weakness, and family history. Patients with muscular weakness or dysfunction of the central nervous system harbored larger CTG expansions than those without each symptom (P < 0.05). The age of onset was inversely correlated with the size of the CTG expansion (gamma=-0.422, P < 0.001). The instability of CTG expansion representing as the maximum difference between sibships was observed from 50 to 700 repeats in nine families. Clinical anticipation and the increase in CTG repeat were significantly higher in maternally transmitted alleles (P=0.002). Conclusions : Molecular genetic tests are not only essential for diagnosis, but also helpful for suggesting the spectrum and relationship between genotype and phenotype in Korean DM1 patients.
引用
收藏
页码:483 / 492
页数:10
相关论文
共 50 条
  • [1] Molecular and clinical spectrum of type 1 myotonic dystrophy
    Kumar, Ashok
    Agarwal, Sarita
    Pradhan, Sunil
    [J]. GENE REPORTS, 2018, 11 : 34 - 41
  • [2] Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum L.P.
    Day J.W.
    [J]. Current Neurology and Neuroscience Reports, 2002, 2 (5) : 465 - 470
  • [3] CORRELATION OF CLINICAL AND MOLECULAR FEATURES IN MYOTONIC DYSTROPHY TYPE 1
    Sedehizadeh, Saam
    Brook, J. David
    Maddison, Paul
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [4] Clinical and Molecular Features of Myotonic Dystrophy Type 1 in Peru
    Milla-Neyra, Karina
    Inca-Martinez, Miguel
    Ortega-Davila, Olimpio
    Marca, Victoria
    Tirado-Hurtado, Indira
    Cabrejo-Bravo, Alex
    Lindo-Samanamud, Saul
    Saraiva-Pereira, Maria-Luiza
    Mazzetti Soler, Pilar
    Jardim, Laura
    Cornejo Olivas, Mario
    [J]. NEUROLOGY, 2016, 86
  • [5] Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1
    Liu, Qing
    Zheng, Yu-Fei
    Zhu, Yan-Ping
    Ling, Shi-Qing
    Li, Wei-Rong
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1931 - 1936
  • [6] Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1
    Peric, Stojan
    Pesovic, Jovan
    Savic-Pavicevic, Dusanka
    Rakocevic Stojanovic, Vidosava
    Meola, Giovanni
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [7] Molecular biomarkers in myotonic dystrophy type 1
    Slipsager, A.
    Hildonen, M.
    Stemmerik, M. Godtfeldt
    Tumer, Z.
    Duno, M.
    Birkedal, U.
    Vissing, J.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S155 - S155
  • [8] Clinical and molecular correlations in myotonic dystrophy type 2
    Day, JW
    Ricker, K
    Dick, KA
    Rasmussen, L
    Dalton, JC
    Jacobsen, JF
    Liquori, CL
    Kress, W
    Schneider, C
    Moseley, ML
    Ranum, LPW
    [J]. NEUROLOGY, 2002, 58 (07) : A226 - A227
  • [9] Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations
    Voermans, N. C.
    van der Bilt, R. C.
    IJspeert, J.
    Hogrel, J. Y.
    Jeanpierre, M.
    Behin, A.
    Laforet, P.
    Stojkovic, T.
    van Engelen, B. G.
    Padberg, G. W.
    Sacconi, S.
    Lemmers, R. J. L. F.
    van der Maarel, S. M.
    Eymard, B.
    Bassez, G.
    [J]. JOURNAL OF NEUROLOGY, 2019, 266 (12) : 2987 - 2996
  • [10] Atrial flutter in myotonic dystrophy type 1: Patient characteristics and clinical outcome
    Wahbi, Karim
    Sebag, Frederic A.
    Lellouche, Nicolas
    Lazarus, Arnaud
    Becane, Henri-Marc
    Bassez, Guillaume
    Stojkovic, Tanya
    Fayssoil, Abdallah
    Laforet, Pascal
    Behin, Anthony
    Meune, Christophe
    Eymard, Bruno
    Duboc, Denis
    [J]. NEUROMUSCULAR DISORDERS, 2016, 26 (03) : 227 - 233